Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

Digital Innovation Hubs in Healthcare Robotics (DIH-HERO)

62 Aufrufe

Veröffentlicht am

Ainara Garzo_Michael Obach, TECNALIA.
Digital Innovation Hubs in Healthcare Robotics (DIH-HERO): Services and Financial support to third parties.

Veröffentlicht in: Präsentationen & Vorträge
  • Als Erste(r) kommentieren

  • Gehören Sie zu den Ersten, denen das gefällt!

Digital Innovation Hubs in Healthcare Robotics (DIH-HERO)

  1. 1. Digital Innovation Hubs in Healthcare Robotics (DIH-HERO): Services and Financial Support to Third Parties Michael Obach & Ainara Garzo Neurorehabilitation Department, TECNALIA Health InfoDay 11 July 2019
  2. 2. Main application domains in Healthcare Robotics Interventional Robotics e.g. surgical robotics Diagnostic Robotics e.g. automated imaging robotics Rehabilitation Robotics e.g. mobile training devices Robotics supporting patients e.g. wearable exoskeletons Robotics supporting healthcare professionals e.g. telepresence robots
  3. 3. Our services (1/2) Technology Services Access to prototyping, research and manufacturing know-how and a technology catalog to speed-up your product development Business Capital and Incubation Links to public and private funding services to transform your technology into a market-ready product Certification and Go-to-Market Services Resources to help you understand customer segments, regulations and value chains to create a perfect market entry strategy
  4. 4. Our services (2/2) Training and Education Services DIH-HERO offers healthcare professionals and robotic developers access to knowledge resources for competence building and life-long learning Data Validation DIH-HERO supports you in the process of gathering, validating and exploiting the data you need Test Infrastructure Services DIH-HERO offers you access to specialized labs and realistic test environments to validate and refine your product or services
  5. 5. Benefits ➢ A sustainable platform for all the stakeholders active in the healthcare ecosystem. ➢ Easy access to information, knowledge and services. ➢ Extended networking and collaboration opportunities. ➢ Extended innovation opportunities through efficient technology transfer. ➢ Financial support regarding travelling, technology demonstrators and technology transfer.
  6. 6. Overview over Financial Support in DIH-HERO Travel Vouchers - 2 calls Technology Demonstrators - 2 calls Technology Transfer Experiment - 1 call https://dih-hero.eu/calls/
  7. 7. Financial support: Definition of an SME ➢ According to the definition of a Small or Medium Enterprise (SME) stated in article 2 of the annex to Recommendation 2003/361 EC ➢ “To count as an SME, your organisation must be engaged in an economic activity and must have: ➢ fewer than 250 employees and ➢ an annual turnover of no more than €50 million and/or a balance sheet of no more than €43 million Whether you count as an SME may depend on how you count your workforce, turnover or balance sheet. Please note that you must take account of any relationships you have with other enterprises. Depending on the category in which your enterprise fits, you may then need to add some, or all of the data.”
  8. 8. Financial support: Travel Voucher (TV) call Purpose ➢ Travel vouchers for cross-border travelling voucher should: ➢ reduce barriers jeopardizing connectivity and ➢ stimulate knowledge exchange.
  9. 9. Financial support: Travel Voucher (TV) call ➢ The first 400 submitted proposals considered eligible will be awarded a TV of max. €2,000 each (max. 400 k€ in the call in 2019). ➢ All applicants will have to execute an SME self-assessment test. ➢ Only legal entities being SMEs and operating in the healthcare and/ or robotics sector within the EU and its associated countries are considered eligible. ➢ Every entity is allowed to submit only one proposal per call. ➢ Proposals must be submitted via the portal. ➢ The voucher can be used during a period of 12 months after awarding. ➢ Payment will be made on a reimbursable basis.
  10. 10. Financial support: Travel Voucher (TV) call Qualifying activities Cross-border traveling in order to visit: ➢ the DIH-HERO brokerage event taking place in October 2019, and/ or ➢ DIH-HERO conferences / network meetings and/or ➢ Digital Innovation Hubs of the DIH-HERO consortium in another country to make usage of their services.
  11. 11. Financial support: Travel Voucher (TV) call Evaluation Criteria Evaluation will be done according to the First-come-first-served principle. The submitted proposals will be reviewed upon: ➢ The date and time of the proposal submission online ➢ The proposals eligibility for travel vouchers
  12. 12. Financial support: Definition of “slightly larger company than an SME” ➢ According to the European Commission, to count as a slightly larger company than an SME, your organisation must be engaged in an economic activity and must have ➢ less than 500 employees and ➢ an annual turnover of no more than €100 million. Whether you count as a slightly larger company than an SME or not may depend on how you count your employees and turnover. Please note that you must take into account any relationships you have with other enterprises. Depending on the category in which your enterprise fits, you may then need to add some, or all of the data.
  13. 13. Financial support: Technology Demonstrator (TD) call Purpose ➢ Stimulate cross-border collaboration ➢ Accelerate the development of Healthcare Robotics by demonstrating the feasibility of new, innovative and enhanced robotic solutions in healthcare application domains. ➢ Improve and broaden the uptake of robotics solutions and increase future investments in robotics in healthcare.
  14. 14. Financial support: Technology Transfer Experiment (TTE) call Purpose ➢ Stimulate cross-border collaboration ➢ Stimulate the transfer of innovative technology from outside the robotics and healthcare domains ➢ Solve unanswered clinical questions ➢ Contribute to overcome implementation hurdles that hinder generating new business for the healthcare robotics industry ➢ Create new links inside the value chain, thereby enabling the societal & economic impact
  15. 15. Financial support: Technology Demonstrator (TD) and Technology Transfer Experiments (TTE) calls Framework Technology Demonstrator and Technology Transfer Experiments must be tailored towards at least one of the following application domains in Healthcare Robotics: ➢ Diagnostic Robotics ➢ Interventional Robotics ➢ Rehabilitation Robotics ➢ Robotics supporting patients ➢ Robotics supporting healthcare professionals
  16. 16. Financial support: Technology Demonstrator (TD) and Technology Transfer Experiments (TTE) call Framework ➢ A consortium must at least consist of: ➢ 1 SME/ slightly larger company and 1 end-user from 2 different countries or ➢ 2 SMEs/ slightly larger companies from 2 different countries ➢ The eligible proposals that have been submitted via the portal will be evaluated by external reviewers and ranked upon excellence, impact and implementation. ➢ For TD: The 35 highest ranked proposals will be awarded ➢ For TTE: The 20 highest ranked proposals will be awarded
  17. 17. Technology Readiness Levels (TRL) A method for estimating the maturity of technologies during the acquisition phase of a program, developed at NASA during the 1970s, adopted by the European Commission: TRL 5 – technology validated in relevant environment TRL 6 – technology demonstrated in relevant environment TRL 7 – system prototype demonstration in operational environment http://as.nasa.gov/aboutus/trl-introduction.html https://en.wikipedia.org/wiki/Technology_readiness_level
  18. 18. Financial Support: Summary Instruments: Travel Voucher (TV) Technology Demonstrator (TD) Technology Transfer Experiment (TTE) Intended result 1. Stimulate knowledge exchange 2. Innovation brokerage by enhanced connectivity 1. Demonstration of a working solution 2. Improving broad uptake & capability to attract future investments 1. Proven feasibility & tech transfer deal by an experiment 2. Integrates a new technology 3. A product generating new business Third Party obtaining Financial Support SME SME or slightly larger company SME or slightly larger company # applicants per proposal 1 ≥ 2 ≥ 2 Max. funding per project 2 k€ 100 k€ 200 k€ Number of projects 400 35 20 Project duration - < 9 months < 15 months TRL - 6-7 5-7 Next call 15 July 2019 Oct 2019 Dec 2019
  19. 19. Financial support Travel Voucher Call Case 1: A Polish SME is planning to participate in the DIH-HERO brokerage event taking place in the Netherlands at the end of October 2019. Answer: This proposal is eligible for a TV of DIH-HERO, as an SME is planning to execute an activity qualifying for a TV up to €2,000.
  20. 20. Financial support Travel Voucher Call Case 2: A Danish midcap wants to visit a German digital innovation hub (DIH) to make use of the services it offers. Answer: Not eligible for a travel voucher of DIH-HERO since although this company wants to visit a DIH in another European country, only SMEs will be awarded a travel voucher in this call.
  21. 21. Financial support Travel Voucher Call Case 3: A German company being an SME according to the criteria would like to use the voucher to take part in a DIH-HERO conference taking place in Munich. Answer: Not eligible for a travel voucher of DIH-HERO since although this company is an SME the intended travel is not cross-border, i.e. not in another European country.
  22. 22. Financial support TD and TTE Case 1: A Belgian SME (250 < X < 500) having an annual turnover of €35 m is aimed to valorise a robotic technology together with a regional university and a hospital in a foreign country. Answer: 1 SME and 1 end-user from 2 different countries are involved in an innovation project. -> Eligible, provided the clinical relevance of the solution.
  23. 23. Financial support TD and TTE Case 2: An Italian university has licensed a technology via a spin-off and they together want to explore possibilities to certify and extend robotic product features by testing it collaborating with a hospital in Germany. Answer: As the spin-off fulfills the criteria of the SME or slightly bigger definitions there are 1 SME and 1 end-user from two different countries involved in project consortium so this proposal is eligible provided that the technology has clinical relevance.
  24. 24. Financial support TD and TTE Case 3: A hospital initiates an experiment idea for a robotic technology provided by an international large company that has an R&D office in the Netherlands (e.g. Medtronic, Philips, GE, Baxter, J&J). Answer: In this case there is no SME involved in the project. => Not eligible
  25. 25. Financial support TD and TTE Case 4: A large company with an R&D office in Germany (e.g. Medtronic, Philips, GE, Baxter) is interested in licensing a SaaS platform from a Dutch large company and is aimed to test it with their robot platform. They will apply for funding together because DIH-HERO connected them with a hospital network from Italy. Answer: DIH-HERO could assist them on connecting them with an SME as well. As soon as an applicable SME has been found it can apply for funding since at least 1 SME and 1 end- user organization are involved in the consortium.
  26. 26. Financial support TD and TTE Case 5: A company fulfilling the definition of a slightly larger company than an SME from Belgium is collaborating with a Dutch SME company working on transferring new technology from outside healthcare robotics to use it for clinical application. In order to get to the following TRL they would like to make use of the test facilities of a Dutch University located in the neighborhood of the SME. Answer: Eligible as there are 2 SMEs or slightly larger companies from 2 different countries involved in the project. The SME or slightly larger company may use the funding to make use of the services of external parties.
  27. 27. This project has received funding from the European Union’s Horizon 2020 research and innovation programm under grant agreement No 825003. Or contact: dih-healthcare@utwente.nl For further information please visit: www.dih-hero.eu Thank you for your attention! Michael Obach Ainara Garzo InfoDay 11 July 2019 michael.obach@tecnalia.com ainara.garzo@tecnalia.com

×